Rutherford-based oncology specialty firm Cancer Genetics Inc. on Tuesday announced it entered into an agreement with MultiPlan Inc., a provider of health care cost management solutions.

As a result of the agreement, Cancer Genetics said it will be able to offer providers with proprietary tests and testing services in hematological and urogenital cancers. MultiPlan contracts with 900,000 health care providers across the United States, and has an estimated 57 million consumers accessing MultiPlan network products, according to the announcement. Terms were not disclosed.